Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer

NCT04646759 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

516

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Fulvestrant combined with Pyrotinib
DRUG: Capecitabine combined with Pyrotinib

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University